发明名称 HYPERICIN AND HYPERICUM EXTRACT: SPECIFIC T-TYPE CALCIUM CHANNEL BLOCKER, AND THEIR USE AS T-TYPE CALCIUM CHANNEL TARGETED THERAPEUTICS
摘要 Hypericin has been shown to specifically inhibit T-type calcium channel activity. Hypericum extract containing hypericin also inhibits T-type calcium channel activity. Moreover, other chemicals in Hypericum extract showed a synergistic effect to hypericin. In view of this, hypericin or hypericin-containing Hypericum extract can be used as T-channel blockers. Hypericum extract, extract of other species of the Hypericum genus, extract of other plants containing hypericin, hypericin derivatives, hypericin analogs, such as pseudohypericin, and other Hypericum extract constituents can be used as therapeutics targeted at T-type calcium channels for treatment of diseases associated with T-channel abnormality. Methods for administering hypericin and Hypericum extract are disclosed.
申请公布号 EP1094712(A1) 申请公布日期 2001.05.02
申请号 EP19990933542 申请日期 1999.07.09
申请人 CV TECHNOLOGIES INC. 发明人 SHAN, JACQUELINE, J.;WU, XI-CHEN;PANG, PETER, K., T.;LING, LEI
分类号 A61K36/18;A61K31/12;A61K31/19;A61K31/215;A61P3/08;A61P3/10;A61P7/00;A61P9/00;A61P9/04;A61P9/06;A61P9/12;A61P25/06;A61P25/08;A61P25/24;A61P25/28;A61P43/00;C07C49/657;C07C49/687;C07C49/703;C07C50/36;C07C65/36;C07C69/00;C07C69/007;C07C69/017;C07C69/95;C07C309/44;C07C309/57;(IPC1-7):A01N65/00;A01N35/00;A01N29/00;C07C17/00;C07C19/08;C07C22/00 主分类号 A61K36/18
代理机构 代理人
主权项
地址